Shanghai MicroPort MedBot (Group) Co., Ltd. announced that its Board has resolved to propose the adoption of a new share scheme designed to incentivize eligible participants for past and potential contributions to the company and its subsidiaries.

The proposed share scheme will allow grants of new shares, options over new shares, and existing shares, bringing the plan under the scope of Chapter 17 of the Hong Kong Listing Rules. Implementation is contingent on two approvals: 1) shareholder consent at a forthcoming general meeting held in accordance with the company’s articles of association, and 2) listing approval from The Stock Exchange of Hong Kong Limited for any new shares to be issued.

Adoption of the new scheme will result in the termination of the company’s existing share award scheme (adopted 10 February 2022) and existing share option scheme (adopted 18 March 2022). To date, no shares or options have been granted under either plan, and the Board does not intend to make awards under the current schemes before the upcoming general meeting.

A circular detailing the principal terms of the proposed share scheme and related matters will be distributed to shareholders as soon as practicable.

The announcement is dated 14 May 2026 and signed by Chairman Dr. Zhaohua Chang.